Call Us08045476402
Mercaptopurine Tablets

Mercaptopurine Tablets

54.00 INR/Box

Product Details:

  • Indication Treatment of acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and other specified hematologic malignancies
  • Dosage Form Tablet
  • Salt Composition Mercaptopurine 50 mg
  • Feature
  • Ingredients Mercaptopurine, Pharmaceutical excipients
  • Application
  • Physical Color/Texture Pale yellow, round, biconvex tablet
  • Click to view more
X

Mercaptopurine Tablets Price And Quantity

  • 54.00 INR/Box
  • 10000 Strip
  • Oral
  • To be used under medical supervision with regular blood count monitoring
  • 50 mg per tablet
  • Hypersensitivity to Mercaptopurine, severe bone marrow suppression
  • Blister pack or bottle
  • Dispensed by registered pharmacist only
  • Prescription only
  • Myelosuppression, nausea, vomiting, liver dysfunction

Mercaptopurine Tablets Product Specifications

  • Odorless
  • Store below 25C, protect from light and moisture
  • Mercaptopurine, Pharmaceutical excipients
  • Treatment of acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and other specified hematologic malignancies
  • 24-36 months
  • Pale yellow, round, biconvex tablet
  • Tablet
  • Mercaptopurine 50 mg
  • Oral
  • To be used under medical supervision with regular blood count monitoring
  • 50 mg per tablet
  • Hypersensitivity to Mercaptopurine, severe bone marrow suppression
  • Blister pack or bottle
  • Dispensed by registered pharmacist only
  • Prescription only
  • Myelosuppression, nausea, vomiting, liver dysfunction

Mercaptopurine Tablets Trade Information

  • MUMBAI
  • Cash Advance (CA), Cash in Advance (CID), Cheque, Western Union
  • 10000 Strip Per Day
  • 01 Week
  • Yes
  • Free samples available with shipping and taxes paid by the buyer
  • 10X10TAB
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India
  • WHO-GMP

Product Description

Mercaptopurine is used alone or with other chemotherapy drugs to treat acute lymphocytic leukemia (ALL; also called acute lymphoblastic leukemia and acute lymphatic leukemia; a type of cancer that begins in the white blood cells). Mercaptopurine is in a class of medications called purine antagonists.

Indications and Application

Mercaptopurine Tablets are indicated for the treatment of acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), and other specified hematologic malignancies. As an antineoplastic agent, Mercaptopurine interrupts abnormal cell proliferation, supporting effective cancer management within chemotherapy regimens.


Administration and Dosage Guidance

Taken orally, Mercaptopurine Tablets are to be used strictly as prescribed by a healthcare provider. Both pediatric and adult dosing must be individualized, and routine blood counts are necessary to monitor for potential myelosuppression and other side effects. The medicine should never be used without supervision.


Storage and Stability

To ensure the efficacy and safety of Mercaptopurine Tablets, store them below 25C and protect from light and moisture. The product retains its stability for 24 to 36 months under recommended conditions. Always check expiration dates and avoid using tablets that appear damaged or discolored.

FAQ's of Mercaptopurine Tablets:


Q: How should Mercaptopurine Tablets be administered?

A: Mercaptopurine Tablets should be taken orally with or without food at the dosage prescribed by your healthcare provider. The treatment plan and dosage are tailored to your specific medical condition and response, requiring strict adherence to your doctor's instructions.

Q: What are the key benefits of Mercaptopurine in leukemia treatment?

A: Mercaptopurine is an effective oral chemotherapeutic agent that slows or stops the growth of abnormal blood cells. Its precise dosage form allows for individualized therapy in both pediatric and adult patients, contributing to better clinical outcomes in leukemia management.

Q: When is blood monitoring necessary during Mercaptopurine therapy?

A: Regular blood count monitoring is mandatory throughout Mercaptopurine treatment. This helps detect myelosuppression or other blood-related side effects early, allowing timely dose adjustments and enhancing patient safety.

Q: Where should I store Mercaptopurine Tablets?

A: Store Mercaptopurine Tablets below 25C in their original packaging, away from light and moisture. Proper storage is crucial for maintaining the tablet's stability and effectiveness throughout the shelf life.

Q: What process should be followed for dispensing Mercaptopurine Tablets?

A: Mercaptopurine Tablets must be dispensed by a registered pharmacist only, and require a valid prescription from a qualified healthcare professional. Pharmacists verify prescription details and counsel patients regarding correct usage and safety precautions.

Q: What common side effects should I be aware of while using Mercaptopurine?

A: The most commonly reported side effects include myelosuppression (reduced blood cell counts), nausea, vomiting, and liver dysfunction. Report any unusual symptoms to your doctor promptly for timely intervention.

Q: Who should avoid Mercaptopurine Tablets?

A: Mercaptopurine is contraindicated in individuals with known hypersensitivity to the medicine or those with severe bone marrow suppression. Always consult your doctor about your medical history before starting therapy.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anticancer Drugs' category



Back to top